DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA.
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
26
12
2018
accepted:
29
03
2019
revised:
08
05
2019
pubmed:
27
4
2019
medline:
19
10
2019
entrez:
27
4
2019
Statut:
epublish
Résumé
Persistent hepatitis B virus (HBV) infection relies on the establishment and maintenance of covalently closed circular (ccc) DNA, a 3.2 kb episome that serves as a viral transcription template, in the nucleus of an infected hepatocyte. Although evidence suggests that cccDNA is the repair product of nucleocapsid associated relaxed circular (rc) DNA, the cellular DNA polymerases involving in repairing the discontinuity in both strands of rcDNA as well as the underlying mechanism remain to be fully understood. Taking a chemical genetics approach, we found that DNA polymerase alpha (Pol α) is essential for cccDNA intracellular amplification, a genome recycling pathway that maintains a stable cccDNA pool in infected hepatocytes. Specifically, inhibition of Pol α by small molecule inhibitors aphidicolin or CD437 as well as silencing of Pol α expression by siRNA led to suppression of cccDNA amplification in human hepatoma cells. CRISPR-Cas9 knock-in of a CD437-resistant mutation into Pol α genes completely abolished the effect of CD437 on cccDNA formation, indicating that CD437 directly targets Pol α to disrupt cccDNA biosynthesis. Mechanistically, Pol α is recruited to HBV rcDNA and required for the generation of minus strand covalently closed circular rcDNA, suggesting that Pol α is involved in the repair of the minus strand DNA nick in cccDNA synthesis. Our study thus reveals that the distinct host DNA polymerases are hijacked by HBV to support the biosynthesis of cccDNA from intracellular amplification pathway compared to that from de novo viral infection, which requires Pol κ and Pol λ.
Identifiants
pubmed: 31026293
doi: 10.1371/journal.ppat.1007742
pii: PPATHOGENS-D-18-02469
pmc: PMC6505960
doi:
Substances chimiques
DNA, Circular
0
DNA, Viral
0
DNA Polymerase I
EC 2.7.7.7
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1007742Subventions
Organisme : NIAID NIH HHS
ID : R01 AI113267
Pays : United States
Déclaration de conflit d'intérêts
I have read the journal's policy and the authors of this manuscript have the following competing interests: [JTG received reserach support and hold stock of Arbutus Biopharma, Inc. JC received research support from Arbutus Biopharma, Inc.]
Références
Trends Cell Biol. 2016 Sep;26(9):640-654
pubmed: 27262731
J Virol. 2001 Jul;75(14):6492-7
pubmed: 11413316
J Virol. 2005 Feb;79(3):1613-22
pubmed: 15650187
Antiviral Res. 2018 Oct;158:185-198
pubmed: 30145242
Nucleic Acids Res. 2001 Aug 1;29(15):3277-88
pubmed: 11470886
Proc Natl Acad Sci U S A. 1987 Feb;84(4):1005-9
pubmed: 3029758
Hepatology. 2015 Dec;62(6):1893-908
pubmed: 26239691
J Virol. 2015 Sep;89(17):9021-8
pubmed: 26085156
PLoS Pathog. 2013 Sep;9(9):e1003613
pubmed: 24068929
J Cell Biol. 2014 Jan 6;204(1):29-43
pubmed: 24379417
J Virol. 2001 Jan;75(1):311-22
pubmed: 11119601
Nature. 1978 Oct 5;275(5679):458-60
pubmed: 692726
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28717041
Science. 2014 Mar 14;343(6176):1221-8
pubmed: 24557838
J Virol. 2017 Sep 27;91(20):
pubmed: 28794020
Cell. 1986 Nov 7;47(3):451-60
pubmed: 3768961
Viruses. 2017 May 22;9(5):
pubmed: 28531167
PLoS One. 2009 Nov 30;4(11):e8093
pubmed: 19956651
Virology. 1983 Dec;131(2):375-84
pubmed: 6659368
J Virol. 2007 Jun;81(12):6164-74
pubmed: 17409153
EMBO J. 2018 Oct 1;37(19):
pubmed: 30104407
PLoS Pathog. 2017 Sep 25;13(9):e1006658
pubmed: 28945802
PLoS Pathog. 2018 Jun 21;14(6):e1007124
pubmed: 29928064
Acta Pharm Sin B. 2014 Aug;4(4):248-57
pubmed: 26579392
Nature. 2018 Aug;560(7716):112-116
pubmed: 30022158
Nature. 2018 Dec;564(7735):278-282
pubmed: 30487602
J Hepatol. 2011 Nov;55(5):996-1003
pubmed: 21376091
J Virol. 2010 Jan;84(1):387-96
pubmed: 19864387
Nat Immunol. 2016 May;17(5):495-504
pubmed: 27019227
Virology. 2015 May;479-480:672-86
pubmed: 25759099
Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):E4244-53
pubmed: 25201958
Antimicrob Agents Chemother. 1997 Aug;41(8):1715-20
pubmed: 9257747
ACS Infect Dis. 2019 May 10;5(5):659-674
pubmed: 29893548
PLoS One. 2012;7(8):e43270
pubmed: 22912842
Nature. 2005 Nov 17;438(7066):379-83
pubmed: 16292314
J Virol. 2017 Aug 10;91(17):
pubmed: 28637752
Nat Chem Biol. 2016 Jul;12(7):511-5
pubmed: 27182663
Antiviral Res. 2015 Oct;122:91-100
pubmed: 26272257
PLoS Genet. 2018 Jan 24;14(1):e1007179
pubmed: 29364907
J Virol. 1996 Jul;70(7):4567-75
pubmed: 8676483
Mol Cell. 2015 Jul 16;59(2):163-175
pubmed: 26145172
Expert Opin Drug Discov. 2017 Jan;12(1):5-15
pubmed: 27797587
J Virol. 2019 May 15;93(11):
pubmed: 30867306
J Virol. 2001 Mar;75(6):2900-11
pubmed: 11222715
Gastroenterology. 2004 Jun;126(7):1750-8
pubmed: 15188170
Vaccine. 2012 Mar 9;30(12):2212-9
pubmed: 22273662
FEBS Lett. 1994 Mar 14;341(1):128-30
pubmed: 8137912
Gut. 2015 Dec;64(12):1972-84
pubmed: 26048673
Cell. 2004 Dec 17;119(6):777-88
pubmed: 15607975
Cell. 2007 Nov 30;131(5):887-900
pubmed: 18001824
Nat Biotechnol. 2008 Mar;26(3):335-41
pubmed: 18297057
PLoS Pathog. 2011 Jun;7(6):e1002084
pubmed: 21698222
Curr Protoc Microbiol. 2018 Nov;51(1):e61
pubmed: 30129235
J Biol Chem. 1989 Mar 15;264(8):4265-8
pubmed: 2647732
J Virol. 2007 Nov;81(22):12472-84
pubmed: 17804499
Clin Liver Dis. 2010 Aug;14(3):397-408
pubmed: 20638021
J Hepatol. 2018 Dec;69(6):1231-1241
pubmed: 30142426
PLoS Pathog. 2016 Oct 26;12(10):e1005893
pubmed: 27783675
Chromosoma. 1997 Nov;106(6):348-60
pubmed: 9362543
Virology. 1990 Mar;175(1):255-61
pubmed: 2155510
PLoS Pathog. 2017 Dec 29;13(12):e1006784
pubmed: 29287110
J Virol. 2016 Apr 14;90(9):4827-4831
pubmed: 26865711
Cell Host Microbe. 2018 Sep 12;24(3):392-404.e8
pubmed: 30173955
Cell Host Microbe. 2016 Dec 14;20(6):798-809
pubmed: 27866901
Prog Mol Biol Transl Sci. 2012;110:207-27
pubmed: 22749147
Hepatology. 2018 Mar;67(3):1127-1131
pubmed: 28877549
J Virol. 1995 Jun;69(6):3350-7
pubmed: 7745682
J Virol. 1995 Jul;69(7):4029-36
pubmed: 7769660
Antiviral Res. 2019 Mar;163:11-18
pubmed: 30639437